Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bettina Aboab is active.

Publication


Featured researches published by Bettina Aboab.


European Journal of Medicinal Chemistry | 2004

Synthesis and biological evaluation of oxindoles and benzimidazolinones derivatives

Samir Messaoudi; Martine Sancelme; Valérie Polard-Housset; Bettina Aboab; Pascale Moreau; Michelle Prudhomme

The synthesis of new oxindoles and benzimidazolinones derivatives bearing a sugar residue on the aromatic nitrogen is described. The presence of the glycoside moiety should enhance the solubility of these heterocyclic compounds and/or improve the interaction with the active site of the biological targets. The inhibitory activities of these new compounds toward five kinases were examined: KDR (VEGFR-2), FGFR-1, PDGFR-beta, EGFR and Tie 2. Furthermore, the antibacterial activities of the prepared compounds were tested against two Gram-positive bacteria Bacillus cereus and Streptomyces chartreusis, a Gram-negative bacterium Escherichia coli and a yeast Candida albicans.


Anti-Cancer Drugs | 2007

In-vitro antiproliferative activities and kinase inhibitory potencies of glycosyl-isoindigo derivatives.

Mathieu Sassatelli; Fadoua Bouchikhi; Bettina Aboab; Fabrice Anizon; Doriano Fabbro; Michelle Prudhomme; Pascale Moreau

In the course of studies on the preparation of potential kinase inhibitors, we were interested in the synthesis of diversely substituted glycosyl-isoindigo derivatives. To get an insight into the effect of the substitution pattern of the isoindigo aromatic and carbohydrate moieties on the biological activities and to identify the cellular target(s) involved in the in-vitro antiproliferative activity of these derivatives, their inhibitory activities toward a panel of 10 different kinases were examined. The best inhibitory activities were found toward cyclin-dependent kinase 2/cyclin A. Molecular modelling experiments were carried out to investigate the binding interactions between the active site of cyclin-dependent kinase 2 and the lead compound of this series.


European Journal of Medicinal Chemistry | 2010

Synthesis and in vitro antiproliferative activities of quinoline derivatives

Sidonie Broch; Bettina Aboab; Fabrice Anizon; Pascale Moreau

The synthesis of new di- and trimeric quinoline derivatives is described as well as their in vitro antiproliferative activities toward a human fibroblast primary culture and two human solid cancer cell lines (MCF-7 and PA 1).


European Journal of Medicinal Chemistry | 2008

Synthesis and biological evaluation of diversely substituted indolin-2-ones.

Fadoua Bouchikhi; Emilie Rossignol; Martine Sancelme; Bettina Aboab; Fabrice Anizon; Doriano Fabbro; Michelle Prudhomme; Pascale Moreau

The synthesis of indolin-2-one derivatives substituted in the 3-position by an aminomethylene group bearing either an ornithine or a lysine residue is described. The inhibitory activities of these compounds toward a panel of eight kinases were examined. Furthermore, the antibacterial activities of the prepared compounds were tested against two Gram-positive bacteria Bacillus cereus and Streptomyces chartreusis, a Gram-negative bacterium Escherichia coli and a yeast Candida albicans.


Bioorganic & Medicinal Chemistry | 2008

Synthesis, checkpoint kinase 1 inhibitory properties and in vitro antiproliferative activities of new pyrrolocarbazoles

Elisabeth Conchon; Fabrice Anizon; Bettina Aboab; Roy M. Golsteyn; Stephane Leonce; Bruno Pfeiffer; Michelle Prudhomme

In the course of structure-activity relationship studies on granulatimide analogues, new pyrrolo[3,4-c]carbazoles have been synthesized in which the imidazole heterocycle was replaced by a five-membered ring lactam system or a dimethylcyclopentanedione. Moreover, the synthesis of an original structure in which a sugar moiety is attached to the indole nitrogen and to a six-membered D ring via an oxygen is reported. The inhibitory activities of the newly synthesized compounds toward checkpoint kinase 1 and their in vitro antiproliferative activities toward three tumor cell lines: murine leukemia L1210, and human colon carcinoma HT29 and HCT116 are described.


Journal of Medicinal Chemistry | 2007

Synthesis and biological activities of new checkpoint kinase 1 inhibitors structurally related to granulatimide.

Elisabeth Conchon; Fabrice Anizon; Bettina Aboab; Michelle Prudhomme


European Journal of Medicinal Chemistry | 2006

Synthesis and antiproliferative activities of indolin-2-one derivatives bearing amino acid moieties

Mathieu Sassatelli; Eric Debiton; Bettina Aboab; Michelle Prudhomme; Pascale Moreau


European Journal of Pharmacology | 2007

Bis-imide granulatimide analogues as potent Checkpoint 1 kinase inhibitors

Hélène Hénon; Samir Messaoudi; Fabrice Anizon; Bettina Aboab; Nathalie Kucharczyk; Stéphane Léonce; Roy M. Golsteyn; Bruno Pfeiffer; Michelle Prudhomme


European Journal of Medicinal Chemistry | 2008

Synthesis, in vitro antiproliferative activities, and Chk1 inhibitory properties of pyrrolo[3,4-a]carbazole-1,3-diones, pyrrolo[3,4-c]carbazole-1,3-diones, and 2-aminopyridazino[3,4-a]pyrrolo[3,4-c]carbazole-1,3,4,7-tetraone.

Elisabeth Conchon; Fabrice Anizon; Bettina Aboab; Roy M. Golsteyn; Stephane Leonce; Bruno Pfeiffer; Michelle Prudhomme


Tetrahedron Letters | 2005

A short and versatile route to chiral spiroketal skeletons

Ahmatjan Tursun; Isabelle Canet; Bettina Aboab; Marie-Eve Sinibaldi

Collaboration


Dive into the Bettina Aboab's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fabrice Anizon

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Pascale Moreau

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bruno Pfeiffer

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge